National Experts in Autoimmunity Tapped to Serve on Exagen’s Scientific Advisory Board
10 déc. 2019 08h10 HE
|
Exagen, Inc.
SAN DIEGO, Dec. 10, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
Exagen extends agreement with GSK for a third year to drive greater awareness about challenges facing lupus diagnosis and management
22 nov. 2019 08h25 HE
|
Exagen, Inc.
SAN DIEGO, Nov. 22, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
Exagen Inc. Announces $26.2 Million Debt Refinancing
21 nov. 2019 08h25 HE
|
Exagen, Inc.
SAN DIEGO, Calif., Nov. 21, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic...
Exagen Inc. to Participate in the 31st Annual Piper Jaffray Healthcare Conference on December 5, 2019
20 nov. 2019 05h15 HE
|
Exagen, Inc.
SAN DIEGO, Nov. 20, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
Exagen Featured in Nine Scientific Presentations at 2019 ACR/ARHP Annual Meeting in Atlanta
28 oct. 2019 08h15 HE
|
Exagen, Inc.
SAN DIEGO, Oct. 28, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
Exagen to Be Honored with National Research Innovation Award by Lupus Foundation of America
21 oct. 2019 08h15 HE
|
Exagen, Inc.
SAN DIEGO, Oct. 21, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
Exagen Announces Publication of Two Key Studies Validating Clinical Performance of AVISE® Lupus in Patients with Probable SLE and Demonstrating Superior Clinical Utility Compared to Standard Diagnostic Testing
15 oct. 2019 08h15 HE
|
Exagen, Inc.
SAN DIEGO, Oct. 15, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
Exagen and the University of Washington Collaborate on Lupus and Rheumatoid Arthritis Research
19 août 2019 08h57 HE
|
Exagen Inc.
San Diego, CA and Albuquerque, NM, Aug. 19, 2019 (GLOBE NEWSWIRE) -- Exagen Inc., an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic...
New Biomarker Available to Offer Insight into Thrombosis for Lupus Sufferers
24 avr. 2019 09h55 HE
|
Exagen Diagnostics, Inc.
San Diego, CA and Albuquerque, NM, April 24, 2019 (GLOBE NEWSWIRE) -- Exagen Inc., a leader in helping rheumatologist and their patients in the diagnosis, prognosis, and management of chronic...
JEFFREY THOMAS ELLIOTT, CFA Joins Exagen’s Board of Directors
26 mars 2019 08h45 HE
|
Exagen Diagnostics, Inc.
San Diego, CA and Albuquerque, NM, March 26, 2019 (GLOBE NEWSWIRE) -- Exagen Inc., an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic...